The EQUINOC Study
This study is looking to see if the investigational medication can help cut down on frquent night-time bathroom use, and reduce the impact that nocturia has on sleep and daily life.
What is the EQUINOC Study?
Men with BPH (Enlarged Prostate) often report that Nocturia (need to wake and pass urine at night) can be one of the most bothersome symptoms that they experience as a result of their condition. Many men adapt their lifestyle to help reduce the number of times that they wake up to use the bathroom. However, this approach may not always work.
This new medication is in the form of a pill that is taken each night before bedtime and is designed to slow down how much urine the body makes at night. It is hoped that it will reduce the number of times that men wake up to use the bathroom.
Prostate gland enlargement is a common condition as men get older. Also called benign prostatic hyperplasia (BPH) and prostatic hypertrophy, prostate gland enlargement can cause bothersome urinary symptoms. Untreated prostate gland enlargement can block the flow of urine out of the bladder and can cause bladder, urinary tract or kidney problems.
Can you take part in the EQUINOC Study?
- Are a man who is at least 18 years of age
- have been diagnosed with an enlarged prostate gland (known as benign prostatic hyperplasia or BPH)
- have been bothered by nocturia for at least 1 year.
Benefits of this study if eligible:
- All study-related medications at no cost
- Medical related assessments by our professional staff at no cost
- Compensation for your time and travel